Skip to main content
OpenTrials
Completed

NCT Number: NCT03771482

Education of Providers on Prescribing Best Practices

This study aims to evaluate the impact of spaced education, delivered via a smartphone application, on provider prescribing patterns.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Education

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

About this study

As part of a medical center educational initiative at Vanderbilt University Medical Center (VUMC), two educational modules will be sent to prescribing providers through either email or short message service (SMS) text messaging. The first educational module consists of a set of multiple choice questions concerning best practices for prescribing intravenous fluids in the inpatient and perioperative setting. This module is based upon recent literature and specifically derived from the results of the Isotonic Solutions and Major Adverse Renal Events Trial (SMART) and Saline Against Lactated Ringer's or Plasma-Lyte in the Emergency Department (SALT-ED) trial, both published in the New England Journal of Medicine in 2018 and led by Vanderbilt investigators. Similarly, a second educational module concerning evidence-based pain management and opioid prescribing practices will be distributed via email or SMS text messaging.

Participants will receive one question per day. If the participant does not answer the question correctly, they will receive the opportunity to attempt the question again after reviewing evidence-based education. All questions have been curated and reviewed by a panel of experts and piloted within VUMC for feasibility and acceptability. Key concepts are repeated in each module and questions are strategically ordered throughout each module to accomplish spaced education.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All inpatient prescribing providers

Exclusion criteria

  • none

Treatment and study plan

Quiztime modules

Behavioral

Text Messaging or Email system

Primary outcomes

  1. Median morphine milligram equivalents (MME) per opioid prescription

    Time frame: 8 months

    By extracting prescribing data for opioids from the electronic health records

  2. Percentage of orders for balanced intravenous (IV) fluid solutions (i.e. not normal saline)

    Time frame: 8 months

    By extracting prescribing data for intravenous fluids from the electronic health records

Secondary outcomes

  1. Chloride levels in patients receiving intravenous fluid orders from a provider enrolled in the study

    Time frame: 8 months

    By extracting chloride level data from the electronic health records

  2. Potassium levels in patients receiving intravenous fluid orders from a provider enrolled in the study

    Time frame: 8 months

    By extracting potassium level data from the electronic health records

  3. Major Adverse Kidney Events by 30 days (MAKE 30) in patients receiving intravenous fluid orders from a provider enrolled in the study

    Time frame: 30 days

    By extracting data from the electronic health records

  4. Length of stay for patients receiving an intravenous fluid order or an opioid prescription from a provider enrolled in the study.

    Time frame: 8 months

    By extracting length of stay data from the electronic health records

  5. Length of stay in the intensive care unit (ICU) for patients receiving an intravenous fluid order or an opioid prescription from a provider enrolled in the study

    Time frame: 8 months

    By extracting ICU length of stay from the electronic health records

  6. Median number of pills per prescription for patients receiving an opioid prescription from a provider enrolled in the study

    Time frame: 8 months

    By extracting medication data from the electronic health records

  7. Percent of opioid prescriptions (inpatient) that also had a scheduled (not pro re nata (PRN)) non-opioid (APAP, nonsteroidal anti-inflammatory drugs (NSAIDs), gamma-Aminobutyric acid (GABA), muscle relaxant, etc.)

    Time frame: 8 months

    By extracting medication data from the electronic health records

  8. Percent of opioid prescriptions (discharge) that also had a scheduled (not PRN) non-opioid (APAP, NSAIDs, GABA, muscle relaxant, etc.)

    Time frame: 8 months

    By extracting medication data from the electronic health records

  9. Number of Rapid Response Team calls (RRT s) indexed to the number of patients cared for per prescriber (evaluated by level of engagement of the learner with QuizTime)

    Time frame: 8 months

    By extracting RRT calls from the electronic health records

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Registry information

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Dec 11, 2018
Registry last updated
Oct 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.